Anti-epidermal growth factor receptor-an
β
Christine Solbach; Marc Roller; Andre Ahr; Sibylle Loibl; Maria Nicoletti; Manfr
π
Article
π
2002
π
John Wiley and Sons
π
French
β 118 KB
π 1 views
Recent studies demonstrated that tumors overexpressing the epidermal growth factor receptor (EGF-R, erbB-1) are associated with poor clinical outcome. This led to the development of a variety of monoclonal antibodies targeting the extracellular domain of this receptor tyrosine kinase. The aim of our